These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34419433)

  • 41. Use of Impella in Patients Listed for Heart Transplantation.
    Pahwa S; Dunbar-Matos C; Slaughter MS; Trivedi JR
    ASAIO J; 2022 Jun; 68(6):786-790. PubMed ID: 35184091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Veno-arterial extracorporeal membrane oxygenation with concomitant Impella versus concomitant intra-aortic-balloon-pump for cardiogenic shock.
    Au SY; Fong KM; Tsang CS; Chan KA; Wong CY; Ng WG; Lee KYM
    Perfusion; 2023 Jan; 38(1):51-57. PubMed ID: 34318736
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of the revised heart allocation policy and the influence of increased mechanical circulatory support on survival.
    Elde S; He H; Lingala B; Baiocchi M; Wang H; Hiesinger W; MacArthur JW; Shudo Y; Woo YJ
    J Thorac Cardiovasc Surg; 2023 Jun; 165(6):2090-2103.e2. PubMed ID: 35027214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The contemporary role of Impella in a comprehensive mechanical circulatory support program: a single institutional experience.
    Pieri M; Contri R; Winterton D; Montorfano M; Colombo A; Zangrillo A; De Bonis M; Pappalardo F
    BMC Cardiovasc Disord; 2015 Oct; 15():126. PubMed ID: 26466899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of Temporary Percutaneous Mechanical Circulatory Support Before Transplantation in the 2018 Heart Allocation System.
    Clerkin KJ; Salako O; Fried JA; Griffin JM; Raikhelkar J; Jain R; Restaino S; Colombo PC; Takeda K; Farr MA; Sayer G; Uriel N; Topkara VK
    JACC Heart Fail; 2022 Jan; 10(1):12-23. PubMed ID: 34969492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Temporary Mechanical Circulatory Support in Patients with Cardiogenic Shock: Clinical Characteristics and Outcomes.
    Abiragi M; Singer-Englar T; Cole RM; Emerson D; Esmailian F; Megna D; Moriguchi J; Kobashigawa JA; Kittleson MM
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intra-aortic Balloon Pump Versus Impella in Managing Cardiogenic Shock After Myocardial Infarction: Literature Review.
    Reist RE; Seidt KA
    Dimens Crit Care Nurs; 2022 Nov-Dec 01; 41(6):321-329. PubMed ID: 36179310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Propensity score-based analysis of 30-day survival in cardiogenic shock patients supported with different microaxial left ventricular assist devices.
    Nersesian G; Potapov EV; Nelki V; Stein J; Starck C; Falk V; Schoenrath F; Krackhardt F; Tschöpe C; Spillmann F
    J Card Surg; 2021 Nov; 36(11):4141-4152. PubMed ID: 34460968
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock.
    Pieri M; Sorrentino T; Oppizzi M; Melisurgo G; Lembo R; Colombo A; Zangrillo A; Pappalardo F
    J Interv Cardiol; 2018 Dec; 31(6):717-724. PubMed ID: 30460719
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction.
    Ouweneel DM; Eriksen E; Sjauw KD; van Dongen IM; Hirsch A; Packer EJ; Vis MM; Wykrzykowska JJ; Koch KT; Baan J; de Winter RJ; Piek JJ; Lagrand WK; de Mol BA; Tijssen JG; Henriques JP
    J Am Coll Cardiol; 2017 Jan; 69(3):278-287. PubMed ID: 27810347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes.
    Varshney AS; Berg DD; Katz JN; Baird-Zars VM; Bohula EA; Carnicelli AP; Chaudhry SP; Guo J; Lawler PR; Nativi-Nicolau J; Sinha SS; Teuteberg JJ; van Diepen S; Morrow DA;
    JAMA Cardiol; 2020 Jun; 5(6):703-708. PubMed ID: 32293644
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impella 5.5 as a bridge to heart transplantation: Waitlist outcomes in the United States.
    Cevasco M; Shin M; Cohen W; Helmers MR; Weingarten N; Rekhtman D; Wald JW; Iyengar A
    Clin Transplant; 2023 Oct; 37(10):e15066. PubMed ID: 37392194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanical circulatory support with the Impella 5.0 device for postcardiotomy cardiogenic shock: a three-center experience.
    Engström AE; Granfeldt H; Seybold-Epting W; Dahm M; Cocchieri R; Driessen AH; Sjauw KD; Vis MM; Baan J; Koch KT; De Jong M; Lagrand WK; Van Der Sloot JA; Tijssen JG; De Winter RJ; De Mol BA; Piek JJ; Henriques JP
    Minerva Cardioangiol; 2013 Oct; 61(5):539-46. PubMed ID: 24096248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined use of Impella device and intra-aortic balloon pump to improve survival in a patient in profound cardiogenic shock post cardiac arrest.
    Gupta A; Allaqaband S; Bajwa T
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):975-6. PubMed ID: 19521993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.
    Cheng JM; den Uil CA; Hoeks SE; van der Ent M; Jewbali LS; van Domburg RT; Serruys PW
    Eur Heart J; 2009 Sep; 30(17):2102-8. PubMed ID: 19617601
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro comparison of support capabilities of intra-aortic balloon pump and Impella 2.5 left percutaneous.
    Schampaert S; van't Veer M; van de Vosse FN; Pijls NH; de Mol BA; Rutten MC
    Artif Organs; 2011 Sep; 35(9):893-901. PubMed ID: 21819436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients.
    Schäfer A; Werner N; Burkhoff D; Sieweke JT; Zietzer A; Masyuk M; Junker Udesen NL; Westenfeld R; Møller JE
    Front Cardiovasc Med; 2020; 7():74. PubMed ID: 32478095
    [No Abstract]   [Full Text] [Related]  

  • 58. The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three-center experience.
    Siegenthaler MP; Brehm K; Strecker T; Hanke T; Nötzold A; Olschewski M; Weyand M; Sievers H; Beyersdorf F
    J Thorac Cardiovasc Surg; 2004 Mar; 127(3):812-22. PubMed ID: 15001911
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment With Impella Increases the Risk of De Novo Aortic Insufficiency Post Left Ventricular Assist Device Implant.
    Rao SD; Johnson B; Olia SE; Wald J; Medina V; Rame JE; Mazurek JA; Goldberg LR; Atluri P; Bermudez C; Acker M; Birati EY
    J Card Fail; 2020 Oct; 26(10):870-875. PubMed ID: 32681883
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Waitlist Trends in Heart-Liver Transplantation With Updated US Heart Allocation System.
    Iyengar A; Weingarten N; Herbst DA; Helmers MR; Kelly JJ; Meldrum D; Dominic J; Guevara-Plunkett S; Atluri P
    Ann Thorac Surg; 2023 Dec; 116(6):1270-1275. PubMed ID: 35987345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.